The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
about
Cardiovascular risk may be increased in women with unexplained infertilityCardiovascular risk factors among women with self-reported infertilityLess but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.Factors associated with presence and extent of coronary calcium in those predicted to be at low risk according to Framingham risk score (from the Multi-Ethnic Study of Atherosclerosis).Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis.Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion.Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials.Inflammation, atherosclerosis, and psoriasis.Impact of different types of tree nut, peanut, and soy nut consumption on serum C-reactive protein (CRP): A systematic review and meta-analysis of randomized controlled clinical trials.THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION.Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment.Burnout and vigor as predictors of the incidence of hyperlipidemia among healthy employees.Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea.Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm).Increased insulin resistance and C-reactive protein in women with complete hydatidiform mole.The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
P2860
Q33575570-6F68DFD0-3A53-4B12-A0E4-125CA9242AFCQ33655058-08627BFE-CC7F-42C1-A63A-9360CCE78A38Q34023089-52B0F4D8-2152-45FB-810B-3E0DC4A98E87Q35238575-BDAA8AAC-212E-414B-B0E8-2A4648818A87Q35846083-87A40528-5F84-457C-BE31-E342090C2EBDQ37228621-E0D20408-37EE-4794-B31D-07252ED7FF7FQ37628338-B516FCB2-ABCE-4823-910D-BC114A4ACF91Q37987473-D675E75A-BA68-4DA2-A21C-CB4F9ECE8580Q39012075-D9997150-C819-4F94-A51E-856A3700DC3EQ39012642-C28EB8CC-213E-4F36-8A1A-12DDD761F011Q40918418-FB0628AF-D8E6-4E66-818C-33B9222C0CB8Q45898714-58B315F0-30DE-438D-BB17-0ED93B94346DQ47330451-405B3DD2-346A-4882-B66A-550A818F7212Q47404076-B060800F-E298-4792-B074-506A916B8E79Q51382843-E991DFF3-9D39-45C0-9D64-F9A0A60F2537Q58696061-CB2702F3-5B91-4545-9609-556CC210E8F6
P2860
The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The therapeutic modulation of ...... hat is the clinical relevance?
@en
The therapeutic modulation of ...... hat is the clinical relevance?
@nl
type
label
The therapeutic modulation of ...... hat is the clinical relevance?
@en
The therapeutic modulation of ...... hat is the clinical relevance?
@nl
prefLabel
The therapeutic modulation of ...... hat is the clinical relevance?
@en
The therapeutic modulation of ...... hat is the clinical relevance?
@nl
P2093
P2860
P921
P1433
P1476
The therapeutic modulation of ...... hat is the clinical relevance?
@en
P2093
Ali A Rizvi
Giovam Battista Rini
Kaspar Berneis
P2860
P2888
P356
10.1007/S00592-008-0057-4
P577
2008-10-17T00:00:00Z